The Monday-Thursday schedule creates a roughly 72-hour gap between injections, which maintains adequate drug levels while providing enough spacing to avoid excessive accumulation
van der Plasse G, van Zessen R, Luijendijk MC, Erkan H, Stuber GD, Ramakers GM et al
New York, Illinois, Ohio, Florida, and New Jersey do not cover obesity-indicated GLP-1s at all only diabetes-approved versions for diabetes patients
More than medicationa complete transformation 2026 WeightLoss GLP-1 Program, VIP Health and Laser Clinic Gainesville, FL
GLP-1 receptor agonists are not routinely recommended during breastfeeding due to limited safety data in lactating populations
Yes, for injectable GLP-1 medications like semaglutide and tirzepatide , there is no absorption interaction between fiber supplements and the injection itself